ClinicalTrials.Veeva

Menu

Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms

V

VU University of Amsterdam

Status

Completed

Conditions

Attention Deficit Hyperactivity Disorder

Treatments

Behavioral: Behavioral Teacher Program

Study type

Interventional

Funder types

Other

Identifiers

NCT02518711
20110028 (Other Grant/Funding Number)
5930790 (Other Grant/Funding Number)
METc VUmc 2011/196

Details and patient eligibility

About

The goal of this study was to investigate the effectiveness of a behavioral teacher program addressing symptoms of Attention-Deficit Hyperactivity Disorder (ADHD) in the classroom.

Full description

Background:

Most behavioral teacher programs involve intensive and expensive teacher trainings by health care specialists, which may limit successful large-scale implementation. This behavioral program, on the contrary, involves a self-containing manual that does not require expert training in order to increase the likelihood of successful implementation (if proven effective). The aim was to investigate the program's effects on behavioral, socio-emotional and school functioning in primary school children.

Methods:

Children with ADHD symptoms were randomly assigned at school level to the intervention condition (receiving the program during 18 weeks) or control group (not receiving the program but who were allowed to receive care as usual).

Measures to assess program's effectiveness:

  • Strengths and Weaknesses of ADHD-symptoms and Normal Behavior,
  • Strengths and Difficulties Questionnaire
  • Social Skills Rating Scale
  • Spence Children's Anxiety Scale
  • Classroom Observation Code
  • Actigraphy
  • Sociometric measures (peer nomination and peer rating)
  • Dutch arithmetic test (Tempo-Test-Rekenen)
  • reading test (Drie-Minuten-Toets) and writing test (PI-dictee).

Additional measures:

  • Wechsler Intelligence Scale for Children (Block Design and Vocabulary; used to estimate IQ);
  • Sensitivity to Punishment and Sensitivity to Reward Questionnaire and several neuropsychological computer tasks

Enrollment

114 patients

Sex

All

Ages

6 to 13 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • sub-threshold or clinical level of ADHD symptoms as observed by participant's teacher through the Dutch version of the Disruptive Behavior Disorders Rating Scale (Pelham, Gnagy, Greenslade, & Milich, 1992)
  • at least one clinical and three sub-threshold ADHD symptoms as measured by the Teacher Telephone Interview (Holmes et al., 2004), a semi-structured interview which is based on the Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2000)

Exclusion criteria

  • (medication) treatment for ADHD at study entry or in preceding 6 months;
  • neurological or severe physical condition
  • IQ < 80 based on a short version of the Wechsler Intelligence Scale for Children (Block Design and Vocabulary; Legerstee, van der Reijden-Lakeman, Lechner-van der Noort, & Ferdinand, 2004; Hrabok, Brooks, Fay-McClymont, & Sherman, 2014)
  • participant enrolled in a daily contingency management program or other teacher program targeting behavior or social problems at study entry or in the preceding month
  • Maximum of 2 children per classroom and 5 classrooms per school (in order to limit teachers' burden and increase heterogeneity of teacher and classroom settings)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

114 participants in 2 patient groups

Behavioral teacher program
Experimental group
Description:
The behavioral teacher program was used by the participant's teacher in the classroom during 18 weeks.
Treatment:
Behavioral: Behavioral Teacher Program
Control group
No Intervention group
Description:
Children within the control group did not receive the behavioral teacher program but were allowed to receive regular care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems